The combination of AZD5438 and PD0325901 exhibited superior tumor-suppressive efficacy compared to either agent alone and further amplified CD8+ T cell-mediated antitumor immunity through the induction of pyroptosis, a form of programmed cell death characterized by its pro-inflammatory nature [19, 20]. The gene discussed is CD8A; the disease is neoplasm.